Significant Ownership of Novo Holdings A/S

Signature - Title
/s/ Barbara Fiorini - By Barbara Fiorini, General Counsel, Finance & Operations
Location
Hellerup
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Novo Holdings A/S.

Notify me when Novo Holdings A/S files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Novo Holdings A/S

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MPLT MAPLIGHT THERAPEUTICS, INC. Voting Common Stock, par value $0.0001 per share 8.4% 3,686,622 Novo Holdings A/S 28 Oct 2025
FDMT 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 6.4% $28,694,793 +$3,739,293 3,650,737 +15% Novo Holdings A/S 31 Dec 2025
AVBP ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share 4.9% 1,872,142 +7% Novo Holdings A/S 30 Jun 2025
ZBIO Zenas BioPharma, Inc. Common Stock, par value $0.0001 4.7% $44,400,000 -$4,772,267 2,000,000 -9.7% Novo Holdings A/S 30 Sep 2025
IOBT IO Biotech, Inc. Common Stock, par value $0.001 per share 3.3% $1,827,160 -$1,859,215 2,469,135 -50% Novo Holdings A/S 21 Jan 2026
EVO Evotec SE Ordinary Shares, no par value per share 0% $0 -$36,408,507 0 -100% Novo Holdings A/S 31 Dec 2025
GLTO Galecto, Inc. Common Stock, par value $0.00001 per share 0% 0 -100% Novo Holdings A/S 07 Oct 2025

Schedules 13D/G Reported by Novo Holdings A/S:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.